Journal
CURRENT MOLECULAR MEDICINE
Volume 21, Issue 10, Pages 860-871Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1566524021666210202114844
Keywords
Cancer; EMT; treatment resistance; stemness; DNA damage repair; molecule interaction
Categories
Ask authors/readers for more resources
Therapy resistance in cancer treatment is a major challenge, with epithelial-to-mesenchymal transition (EMT) playing a crucial role. The molecular mechanisms of the EMT program, DNA damage response, and therapeutic resistance are complex and interconnected. Various molecular signals, including EMT-TFs, collaborate to induce EMT and enhance therapy resistance through an enhanced DNA damage repair system.
Therapy resistance remains the major obstacle to successful cancer treatment. Epithelial-to- mesenchymal transition [EMT], a cellular reprogramming process involved in embryogenesis and organ development and regulated by a number of transcriptional factors [EMT-TFs] such as ZEB1/2, is recognized for its role in tumor progression and metastasis. Recently, a growing body of evidence has implicated EMT in cancer therapy resistance, but the actual mechanism that underlies this finding has remained elusive. For example, whether it is, the EMT states in itself or the EMT-TFs that modulate chemo or radio-resistance in cancer is still contentious. Here, we summarise the molecular mechanisms of the EMT program and chemotherapeutic resistance in cancer with specific reference to DNA damage response [DDR]. We provide an insight into the molecular interactions that exist between EMT program and DNA repair machinery in cancer and how this interaction influences therapeutic response. We review conflicting studies linking EMT and drug resistance via the DNA damage repair axis. We draw scientific evidence demonstrating how several molecular signalling, including EMT-TFs, work in operational harmony to induce EMT and confer stemness properties on the EMT-susceptible cells. We highlight the role of enhanced DNA damage repair system associated with EMT-derived stem cell-like states in promoting therapy resistance and suggest a multi-targeting modality in combating cancer treatment resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available